With over 30 years of experience, Blanver is a leading excipient manufacturer in South America of high quality products for the food, pharmaceutical, veterinary, nutraceutical, cosmetics and agro-industries. The company’s business is centered on finished dosage formulations and raw materials for the food and pharmaceutical industries. In raw materials, they work with active pharmaceutical ingredients (APIs), pharmaceutical excipients and food ingredients. In medicines, they develop and manufacture high quality producta in the HIV, hepatitis and osteoporosis segments. Blanvers excipient division Itacel is now acquired by Roquette.